Results 11 to 20 of about 62,977 (50)

Real world pharmacovigilance assessment of drug related macular degeneration risks. [PDF]

Sci Rep
Chen X, Wu S, Wang S, Yu C, Guo Z, Huang S, Cai P, Miao Y, Li S, Chen Q.   +9 more
europepmc   +1 more source

NLRP3 Activation With Bisphosphonate Use and the Risk of Incident Age-Related Macular Degeneration. [PDF]

Invest Ophthalmol Vis Sci
Magagnoli J, Cummings T, Hardin JW, Sutton SS, Ambati J.   +4 more
europepmc   +1 more source

Oculomotor challenges in macular degeneration impact motion extrapolation. [PDF]

J Vis
Rubinstein JF, Alcalde NG, Chopin A, Verghese P.   +3 more
europepmc   +1 more source

Crocus sativus (saffron) and age-related macular degeneration. [PDF]

Med Hypothesis Discov Innov Ophthalmol
Shamabadi A, Asadigandomani H, Kazemzadeh K, Farahmand K, Arabzadeh Bahri R, Akhondzadeh S.   +5 more
europepmc   +1 more source

The Past, Present, and Future Perspective of Photodynamic Therapy for Age-Related Macular Degeneration. [PDF]

J Clin Med
Honda S.
europepmc   +1 more source

Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration. [PDF]

Antioxidants (Basel)
Li X, Zhao L, Zhang B, Wang S.
europepmc   +1 more source

Advances in the Study of Age-Related Macular Degeneration Based on Cell or Cell-Biomaterial Scaffolds. [PDF]

Bioengineering (Basel)
Li Z, Hu Z, Gao Z.
europepmc   +1 more source

Intravitreal Administration of Avacincaptad Pegol in a Nonhuman Primate Model of Dry Age-Related Macular Degeneration. [PDF]

Pharmacol Res Perspect
Fujii R, Matsushita M, Itani Y, Hama A, Natsume T, Takamatsu H.   +5 more
europepmc   +1 more source

Recurrence of neovascular age-related macular degeneration after discontinuation of modified treat and extend treatment. [PDF]

Sci Rep
Lee J, Choi J, Yu SY, Kim K.
europepmc   +1 more source

Nocturnal hypoxia and age-related macular degeneration. [PDF]

Clin Exp Ophthalmol
Chaudhary A, Abbott CJ, Wu Z, Fang WY, Raj PR, Naughton M, Heriot WJ, Guymer RH.   +7 more
europepmc   +1 more source